PiR-168112 was also downregulated in the PDAC and IPMN samples compared to tumour cell lines (Log2 fold change = –26.81; adjusted p-value = 1.31 × 10−15). The gene discussed is PIR; the disease is pancreatic intraductal papillary-mucinous neoplasm.